These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
662 related articles for article (PubMed ID: 28268222)
21. FBXO2 promotes the progression of papillary thyroid carcinoma through the p53 pathway. Guo W; Ren Y; Qiu X Sci Rep; 2024 Sep; 14(1):22574. PubMed ID: 39343799 [TBL] [Abstract][Full Text] [Related]
22. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer. Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868 [TBL] [Abstract][Full Text] [Related]
23. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma. Romitti M; Wajner SM; Ceolin L; Ferreira CV; Ribeiro RV; Rohenkohl HC; Weber Sde S; Lopez PL; Fuziwara CS; Kimura ET; Maia AL Endocr Relat Cancer; 2016 Mar; 23(3):135-46. PubMed ID: 26825960 [TBL] [Abstract][Full Text] [Related]
24. Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma. Yin DT; Xu J; Lei M; Li H; Wang Y; Liu Z; Zhou Y; Xing M Oncotarget; 2016 Feb; 7(5):5830-41. PubMed ID: 26716505 [TBL] [Abstract][Full Text] [Related]
25. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
26. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7. Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989 [TBL] [Abstract][Full Text] [Related]
28. Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma. Lu ZW; Wen D; Wei WJ; Han LT; Xiang J; Wang YL; Wang Y; Liao T; Ji QH Oncol Rep; 2020 Mar; 43(3):783-794. PubMed ID: 31922231 [TBL] [Abstract][Full Text] [Related]
29. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer. Garcia-Rendueles AR; Rodrigues JS; Garcia-Rendueles ME; Suarez-Fariña M; Perez-Romero S; Barreiro F; Bernabeu I; Rodriguez-Garcia J; Fugazzola L; Sakai T; Liu F; Cameselle-Teijeiro J; Bravo SB; Alvarez CV Oncogene; 2017 Feb; 36(5):652-666. PubMed ID: 27452523 [TBL] [Abstract][Full Text] [Related]
30. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma. Ye WC; Gao L; Huang J; Fang XM; Xie G Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837 [TBL] [Abstract][Full Text] [Related]
31. [In vitro and in vivo inhibitory effect of Ad-ING4 gene on proliferation of human prostate cancer PC-3 cells]. Yang HC; Sheng WH; Xie YF; Miao JC; Wei WX; Yang JC Ai Zheng; 2009 Nov; 28(11):1149-57. PubMed ID: 19895734 [TBL] [Abstract][Full Text] [Related]
32. RASSF10 is epigenetically inactivated and induces apoptosis in lung cancer cell lines. Wang Y; Ma T; Bi J; Song B; Zhou Y; Zhang C; Gao M Biomed Pharmacother; 2014 Apr; 68(3):321-6. PubMed ID: 24433832 [TBL] [Abstract][Full Text] [Related]
33. Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway. Fu J; Lv H; Guan H; Ma X; Ji M; He N; Shi B; Hou P BMC Cancer; 2013 Oct; 13():462. PubMed ID: 24098937 [TBL] [Abstract][Full Text] [Related]
34. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma. Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299 [TBL] [Abstract][Full Text] [Related]
35. Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer. Zhao H; Li J; Li X; Han C; Zhang Y; Zheng L; Guo M Curr Protein Pept Sci; 2015; 16(4):316-21. PubMed ID: 25929866 [TBL] [Abstract][Full Text] [Related]
36. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells. Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106 [TBL] [Abstract][Full Text] [Related]
37. ACAP3 negatively regulated by HDAC2 inhibits the malignant development of papillary thyroid carcinoma cells. Zhan F; Zhang R; Qiu L; Ren Y Int J Biochem Cell Biol; 2024 Sep; 174():106635. PubMed ID: 39098591 [TBL] [Abstract][Full Text] [Related]
38. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis. Zhang H; Teng X; Liu Z; Zhang L; Liu Z J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589 [TBL] [Abstract][Full Text] [Related]
39. Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer. Jeong S; Lee J; Kim D; Seol MY; Lee WK; Jeong JJ; Nam KH; Jung SG; Shin DY; Lee EJ; Chung WY; Jo YS Medicine (Baltimore); 2016 Jan; 95(4):e2592. PubMed ID: 26825907 [TBL] [Abstract][Full Text] [Related]
40. Ziyuglycoside I Inhibits the Proliferation of MDA-MB-231 Breast Carcinoma Cells through Inducing p53-Mediated G2/M Cell Cycle Arrest and Intrinsic/Extrinsic Apoptosis. Zhu X; Wang K; Zhang K; Zhang T; Yin Y; Xu F Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27879682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]